In a country where counterfeit drugs kill over 100,000 people annually, a 22-person startup isn't just building software—they're building trust. Medsaf is the quiet infrastructure layer making Nigeria's pharmaceutical supply chain work, one verified medication at a time.

"Medsaf isn't selling software—they're selling the impossible: verified trust in a broken system."

The real innovation isn't flashy AI or blockchain. It's the operational discipline to deliver $2.2M in revenue with just 22 people—that's $100K per employee, a ratio that screams efficiency in a market where most startups burn cash chasing scale. Their social presence (@medsafcom) is minimal, their website traffic is zero (likely gated or enterprise-focused), and their funding remains undisclosed. This is a company building revenue, not headlines.

• Quality Control as a Service (QaaS) model—unlike typical SaaS, they own the physical verification layer
• Nigeria-first strategy: solving a local problem with global tech standards
• Enterprise-grade operations: 22 employees generating $2.2M revenue suggests high-value contracts, not consumer churn
• Stealth growth: Zero public traffic indicates B2B/enterprise focus with direct sales, not viral marketing